QNTM_OUT_1 [2025-03-27 11:06:34 -0400] 2395 Bytes | 672 tokens | Cum: 672 tkns (8.40% of 8k)
==========================================================================

We're scouting for winners today. Its 11:06:32 AM on Thu Mar 27, 2025 -0400 and I'm looking at Quantum Biopharma (QNTM) up to 8.62 from 6.95

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for Quantum Biopharma:

C1 - Today 07:00AM - Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors
C2 - Mar-26-25 07:00AM - Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd Alcohol Detox Product Lineup for Retail Sales
C3 - Mar-20-25 08:09AM - Quantum Group purchases additional $1.5M worth of Bitcoin
C4 - Mar-20-25 08:09AM 07:30AM - Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
C5 - Mar-17-25 11:33AM - Quantum BioPharma Unaware of Any Material Change
C6 - Mar-07-25 03:00PM - Quantum BioPharma Provides Corporate Update
C7 - Feb-28-25 11:30AM - Psychedelic: GH Research, Compass Pathways report earnings results
C8 - Feb-26-25 07:30AM - Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302

Prior AI Reports for QNTM:

1. 2025-03-27 – Score: – – Target: – – Highs: – / – / –

2. 2025-03-26 – Score: 80 – Target: 8.5700 – Highs: 7.5994 / – / –
bullish-stock-trend-observed-despite-operational-underperformance

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Quantum Biopharma (QNTM)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

QNTM_OUT_3 [2025-03-27 11:06:40 -0400] 1107 Bytes | 344 tokens | Cum: 1018 tkns (12.72% of 8k)
==========================================================================

Showing C1 (chunk 1 of 15): C1:
**Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors**
Date: Today 07:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/27/3050399/0/en/Quantum-Biopharma-Announces-Leading-Crusader-Against-Naked-Short-Selling-and-Stock-Manipulation-Terry-Lynch-Elected-to-Board-of-Directors.html

March 27, 2025 07:00 ET| Source:Quantum BioPharmaQuantum BioPharma

TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce the appointment of Terry Lynch to its board of directors. Mr. Lynch will be replacing Dr. Sanjiv Chopra, who has resigned from his position on the board. The Company thanks Dr. Chopra for his contribution so far. Dr. Chopra will continue to serve as an a

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QNTM_OUT_5 [2025-03-27 11:06:41 -0400] 1003 Bytes | 270 tokens | Cum: 1354 tkns (16.93% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-27T11:20:00Z - Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Ter...
A2 - 2025-03-27T11:06:09Z - Quantum BioPharma adds Terry Lynch to its board By Investing.com...
A3 - 2025-03-27T11:16:13Z - Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Ter...
A4 - 2025-03-27T11:10:45Z - Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Ter...
A5 - 2025-03-27T11:06:17Z - Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Ter...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

QNTM_OUT_7 [2025-03-27 11:06:46 -0400] 1099 Bytes | 333 tokens | Cum: 1689 tkns (21.11% of 8k)
==========================================================================

Showing A1 (chunk 1 of 16): A1:
**Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors**Date: 2025-03-27Source: {'uri': 'manilatimes.net', 'dataType': 'news', 'title': 'The Manila times'}URL: https://www.manilatimes.net/2025/03/27/tmt-newswire/globenewswire/quantum-biopharma-announces-leading-crusader-against-naked-short-selling-and-stock-manipulation-terry-lynch-elected-to-board-of-directors/2081276TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce the appointment of Terry Lynch to its board of directors. Mr. Lynch will be replacing Dr. Sanjiv Chopra, who has resigned from his position on the board. The Company thanks Dr. Chopra for his contribution so far. Dr. Chopra will continue to serve as an advisor to the co

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QNTM_OUT_9 [2025-03-27 11:06:48 -0400] 353 Bytes | 101 tokens | Cum: 1861 tkns (23.26% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-02-06T20:22:10Z - Quantum BioPharma Shares Are Up Over 80%: What's Going On?

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

QNTM_OUT_11 [2025-03-27 11:06:54 -0400] 607 Bytes | 183 tokens | Cum: 2046 tkns (25.57% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Quantum BioPharma Shares Are Up Over 80%: What's Going On?**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/financing/25/02/43543264/quantum-biopharma-shares-are-up-over-80-whats-going-onQuantum BioPharma shares surged over 80% after its licensee, Celly Nutrition, engaged a New York investment bank to raise $10 million and explore a potential U.S. initial public offering.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

QNTM_OUT_13 [2025-03-27 11:06:55 -0400] 238 Bytes | 59 tokens | Cum: 2190 tkns (27.38% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

QNTM_OUT_15 [2025-03-27 11:07:11 -0400] 3252 Bytes | 829 tokens | Cum: 3022 tkns (37.77% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------+-----------------------+----------------------+------------------------+----------------------+---------------------+
| Volume: 507,671 | SMA50: 46.03% | Market Cap: 16.78M | Option/Short: No / Yes | Sales past 5Y: 0.00% | Sales Surprise: - |
+-------------------+-----------------------+----------------------+------------------------+----------------------+---------------------+
| Avg Volume: 2.60M | SMA200: 44.47% | Shs Outstand: 1.86M | Short Float: 3.09% | Employees: - | EPS Surprise: 0.00% |
+-------------------+-----------------------+----------------------+------------------------+----------------------+---------------------+
| Rel Volume: 0.79 | Perf Week: 29.48% | Shs Float: 1.59M | Short Ratio: 0.02 | Debt/Eq: 0.02 | P/E: - |
+-------------------+-----------------------+----------------------+------------------------+----------------------+---------------------+
| RSI (14): 65.41 | Perf Month: 51.47% | Inst Own: 3.64% | Short Interest: 0.05M | Sales Y/Y TTM: - | Earnings: Nov 13 |
+-------------------+-----------------------+----------------------+------------------------+----------------------+---------------------+
| ATR (14): 1.25 | Perf Quarter: 172.27% | Insider Own: 17.20% | Beta: 0.15 | ROE: -67.43% | |
+-------------------+-----------------------+----------------------+------------------------+----------------------+---------------------+
| SMA20: 59.03% | Index: - | Insider Trans: 0.00% | Sales Q/Q: - | ROI: -64.42% | |
+-------------------+-----------------------+----------------------+------------------------+----------------------+---------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 8.9968
Average Volume: 637415.91
30-Day High: 8.9968
30-Day Low: 4.22
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

QNTM_OUT_17 [2025-03-27 11:07:13 -0400] 676 Bytes | 167 tokens | Cum: 3395 tkns (42.44% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

QNTM_IN_19 [2025-03-27 11:07:14 -0400] 126 Bytes | 29 tokens | Cum: 3452 tkns (43.15% of 8k)
==========================================================================

====================================
[2025-03-27 08:07:14] # Analysis Completed
Elapsed Time: 42.40 seconds